Clinical Report: Utilizing the Charlson Comorbidity Index for Long-term Mortality Risk

Overview

This study evaluates the association between the Charlson Comorbidity Index (CCI) and long-term all-cause mortality in elderly patients with acute myocardial infarction (AMI). Findings indicate that while higher CCI scores correlate with increased mortality, CCI did not independently predict long-term outcomes after multivariable adjustment.

Background

Acute myocardial infarction (AMI) is a significant cause of mortality among older adults, who often present with multiple chronic conditions. The Charlson Comorbidity Index (CCI) serves as a tool to quantify comorbidity burden, yet its effectiveness in long-term risk stratification for elderly AMI patients has not been thoroughly investigated.

Data Highlights

Key Findings

• 98 patients (28.0%) died during a median follow-up of 40.9 months.
• All-cause mortality increased with higher CCI scores: 16.95% (low), 29.58% (moderate), and 40.00% (high).
• Univariable Cox analysis showed CCI score was significantly associated with all-cause mortality (HR = 1.164, P = 0.002).
• In multivariable Model 1, smoking history (HR = 1.862, P = 0.003) was associated with worse prognosis, while PCI receipt (HR = 0.497, P = 0.001) was linked to lower mortality.
• CCI did not reach statistical significance for long-term mortality after adjustment (HR = 1.089, P = 0.125).
• Subgroup analyses indicated higher mortality risk in patients with chronic kidney disease or heart failure.

Clinical Implications

The findings indicate that CCI can help characterize comorbidity burden in elderly AMI patients, but its independent predictive ability for long-term mortality is limited.

Conclusion

Higher CCI scores correlate with increased long-term mortality in elderly AMI patients, but CCI's independent predictive ability is limited.

Related Resources & Content

1. Clinical Research in Cardiology, 2023 -- Evaluating the Prognostic Value of a Multi-Biomarker Approach in Individuals with Suspected Myocardial Infarction
2. Frontiers in Cardiovascular Medicine, 2026 -- Utility of Tei Index, carotid IMT, and crouse score in coronary artery calcification assessment and MACCE prediction in elderly patients
3. Frontiers in Medicine, 2026 -- LDAR Outperforms Other Albumin-Derived Indices in Predicting 28-Day ICU Mortality in Critically Ill Myocardial Infarction Patients: A Two-Cohort Study
4. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes, JACC, 2025
5. 2023 ESC Guidelines for the management of acute coronary syndromes, European Heart Journal, 2023
6. Multimorbidity in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis, JACC: Advances, 2025
7. Drugs - Real World Outcomes — Association of Anticholinergic Medication Use at Hospital Admission with Mortality Rates in Elderly Patients: A Nationwide Cohort Study from Denmark
8. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC
9. 2023 ESC Guidelines for the management of acute coronary syndromes | European Heart Journal | Oxford Academic
10. Multimorbidity in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis | JACC: Advances